Skip to content

Effect of Aloe Vera gel on prevention of pressure sore among patients hospitalized in orthopedic ward

Effect of Aloe Vera gel on prevention of pressure sore among patients hospitalized in orthopedic ward

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016051027825N1
Enrollment
80
Registered
2016-09-07
Start date
2016-06-25
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pressure Ulser. Decubitus ulcer and pressure area

Interventions

Intervention 1: Intervention group :At first some pure Aloe Vera gel is tested on Inside of the forearm and in the absence of an allergic reaction, at a later stage pure Aloe Vera gel is applied twice
Prevention
Placebo
Intervention group :At first some pure Aloe Vera gel is tested on Inside of the forearm and in the absence of an allergic reaction, at a later stage pure Aloe Vera gel is applied twice a day (at 9a.m
control group: the researcher moisturizes the same areas by placebo (gel, water and starch) using an applicator and removes the material from the skin by a tissue. Sacrum, hip and heel are controlled

Sponsors

Arak University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
77 Years to 30 Years

Inclusion criteria

Inclusion criteria: The inclusion criteria will be: Lack of skin diseases (like psoriasis, fungal diseases; Vitiligo); patients over 18 years and below 65; patients diagnosed by a nurse as a ‘risk for impaired skin integrity’, by applying the Braden Scale for prediction of pressure ulcer risk showing a high risk or moderated risk (score under14); willingness to participate in the research; not having pressure ulcers; possibility of Continuity of orthopedics ward hospitalization ;being receptioned more than 24 hours in orthopedic ward and not being already admitted in another part; The lack of systemic disease, diabet, Bleeding from injury, heart failer, renal failer and advanced phase of cancer; Having a systolic blood pressure of 10 mm Hg or higher; not receiving vasoactive drugs; lack of drug addiction; temperature under 38.8; hemoglobin upper than 12. Exclusion criteria: The patient declining to take part in research; the patient death; hemoglobin reduction level during the study in men below 12 and in women below 10 mg /dl; receiving vasoactive drugs; anemia,hypotention, hyperthermia during the study.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
The incidence of pressure ulcers. Timepoint: The third day, seventh, tenth after intervention. Method of measurement: check list of daily erythema, temperature, edema and pain.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Mehrabi

Arak University of Medical Sciences

fmehrabi1392@gmail.com; f.mehrabi@arak.mu.ac.ir+98 86 3417 3503

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 23, 2026